Press releases
-
11 May 2012
NOTICE OF ANNUAL GENERAL MEETING OF KARO BIO AB (PUBL)
Stockholm, May 11, 2012 - The shareholders of Karo Bio AB (publ) are hereby given notice to attend the annual general meeting on June 12th, 2012, at 4.00 pm CET at Hörsalen, Novum Forskningspark (level 4 – elevator E), Hälsovägen 7, Huddinge, Sweden.
-
27 April 2012
EXTRAORDINARY GENERAL MEETING IN KARO BIO
-
27 April 2012
INTERIM REPORT JANUARY - MARCH 2012
-
02 April 2012
COLLABORATION WITH ZYDUS CADILA EXPIRES – KARO BIO CONTINUES TO DEVELOP SAFER GLUCOCORTICOIDS
STOCKHOLM, 2 April 2012 – Karo Bio AB (publ) and the Indian pharmaceutical company Zydus Cadila have decided not to further extend their joint glucocorticoid receptor research and development program. Karo Bio focuses its continued development towards a previously not described mechanism of glucocorticoid regulation.
-
23 March 2012
CHANGED DATE FOR THE ANNUAL GENERAL MEETING AND NOTICE TO EXTRAORDINARY GENERAL MEETING OF KARO BIO
-
21 February 2012
KARO BIO LAYS OFF 16 EMPLOYEES
-
14 February 2012
KARO BIO TERMINATES THE EPROTIROME PROGRAM
STOCKHOLM, February 14, 2012 - Karo Bio AB (publ) has decided to discontinue the development program for eprotirome after an animal study has demonstrated unwanted effects following long-term exposure. The planned spin-off of the preclinical part of operations will not proceed.
-
13 February 2012
Information regarding trading suspension
-
08 February 2012
INTERIM REPORT JANUARY - DECEMBER 2011
